Clinical Trial Update: Chinese Herb Nephropathy Epidemiology and Association With CYP2D6, CYP2C19, PXR, or MDR1 Polymorphism

View source ↗

Summary

A clinical trial update examining Chinese herb nephropathy and its possible associations with CYP2D6, CYP2C19, PXR, and MDR1 genetic polymorphisms.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nephropathy

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Kidney Diseases | Status: UNKNOWN